A detailed history of Simplex Trading, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 6,204 shares of CABA stock, worth $25,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,204
Holding current value
$25,870
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$7.22 - $18.82 $44,792 - $116,759
6,204 New
6,204 $46,000
Q3 2022

Nov 04, 2022

BUY
$0.63 - $2.05 $12,506 - $40,694
19,851 Added 445.19%
24,310 $15,000
Q2 2022

Aug 03, 2022

SELL
$0.99 - $2.11 $14,925 - $31,810
-15,076 Reduced 77.17%
4,459 $4,000
Q1 2022

May 02, 2022

SELL
$1.68 - $3.92 $24,701 - $57,635
-14,703 Reduced 42.94%
19,535 $39,000
Q4 2021

Feb 23, 2022

BUY
$3.36 - $14.64 $96,287 - $419,538
28,657 Added 513.47%
34,238 $129,000
Q2 2021

Aug 12, 2021

BUY
$7.2 - $11.73 $34,300 - $55,881
4,764 Added 583.11%
5,581 $47,000
Q1 2021

Apr 26, 2021

BUY
$10.39 - $14.53 $8,488 - $11,871
817 New
817 $9,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $121M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.